|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.83 USD | -6.15% |
|
+1.10% | +218.26% |
| 07-01 | Ocugen, Inc.(NasdaqCM:OCGN) added to Russell Small Cap Completeness Index | CI |
| 07-01 | Ocugen, Inc.(NasdaqCM:OCGN) added to Russell Microcap Growth Index | CI |
(Reuters) - Ocugen Inc said on Monday the COVID-19 vaccine developed by its Indian partner Bharat Biotech International Ltd met the main goal of a trial in the United States.
(Reporting by Leroy Leo in Bengaluru; Editing by Savio D'Souza)
| 1st Jan change | Capi. | |
|---|---|---|
| +218.26% | 471M | |
| +24.74% | 47.54B | |
| -0.47% | 41.96B | |
| +45.60% | 41.55B | |
| +25.40% | 30.36B | |
| +17.96% | 27.61B | |
| -4.47% | 28.7B | |
| +50.73% | 14.7B | |
| +42.56% | 13.51B | |
| +1.46% | 12.34B |
OCUGEN, INC. 
